Clinuvel Pharmaceuticals Limited (CUVL)

Clinuvel Pharmaceuticals Revenue

Clinuvel Pharmaceuticals had revenue of 36.93M AUD in the half year ending December 31, 2025, with 12.59% growth. This brings the company's revenue in the last twelve months to 96.30M, up 5.80% year-over-year. In the fiscal year ending June 30, 2025, Clinuvel Pharmaceuticals had annual revenue of 95.02M with 7.76% growth.

• Revenue (ttm): 96.30M AUD
• Revenue Growth: +5.80%
• P/S Ratio: 5.86
• Revenue / Employee: 6,018,887 AUD
• Employees: 16
• Market Cap: 376.65M USD

Revenue Chart

Chart

Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	95.02M	6.84M	7.76%
Jun 30, 2024	88.18M	9.86M	12.59%
Jun 30, 2023	78.32M	12.60M	19.17%
Jun 30, 2022	65.72M	17.40M	36.02%
Jun 30, 2021	48.32M	15.75M	48.37%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 20, 2026

Data Sources Report a data error